Bernstein SocGen on Elevance (ELV): 'ELV announces market exits in Medicaid'

July 16, 2026 8:53 AM

Bernstein SocGen Group analyst Lance Wilkes reiterated an Outperform rating and $482.00 price target on Elevance (NYSE: ELV).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found